RENO, Nev., May 18, 2011 /PRNewswire/ — Visual Healthcare Corp.
(the “Company”) (NASDAQ OTC: VSHC) announces its decision to start
selling a stand alone version of its powerful adverse drug event
prevention technology to medical facilities and hospitals. The
company is rolling out this new focused version as a direct
response to the Obama administration 1 billion dollar
patient-safety program aimed at reducing preventable medical
errors.
The stand alone version, still running on an Oracle (ORCL) data
base, will be installed in a matter of weeks and operational
immediately as it requires minimal training for clinicians. The
resulting cost savings are passed on to the hospital which can then
recoup its investment in less than a year. Adverse drug events
represent a serious financial concern as they cost an average of
some $7,000 per case, adding up to an annual burden in the
millions.
“We will be signing deals in the next 30 days which could have
an impact as early as the current quarter,” says Chairman Gerard
Dab. “Pressure from the White House is having a strong impact
on the marketplace. Early adopters seeking to move ahead will be
signing some 20 deals having a value of more than 15M in the next
12 months. Subsequently as budgets increase, growth of this product
line will continue to be exponential,” concludes Mr. Dab.
This watershed program follows the publishing of a study showing
that one in three patients admitted to hospitals suffers a medical
error or accident. Through this program, President Obama is
challenging hospitals to dramatically cut mistakes and readmissions
due to preventable errors or negligence by 40 percent and cutting
preventable hospital readmissions by 20 percent. The first tranche
of 1 billion is being funneled to the industry under the Patient
Protection and Affordable Act.
“Reducing the massive incidence of drug errors in hospital can
only be achieved by automation and using smart systems like
ours,”
‘/>”/>
